Corante

About this Author
DBL%20Hendrix%20small.png College chemistry, 1983

Derek Lowe The 2002 Model

Dbl%20new%20portrait%20B%26W.png After 10 years of blogging. . .

Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He's worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer's, diabetes, osteoporosis and other diseases. To contact Derek email him directly: derekb.lowe@gmail.com Twitter: Dereklowe

Chemistry and Drug Data: Drugbank
Emolecules
ChemSpider
Chempedia Lab
Synthetic Pages
Organic Chemistry Portal
PubChem
Not Voodoo
DailyMed
Druglib
Clinicaltrials.gov

Chemistry and Pharma Blogs:
Org Prep Daily
The Haystack
Kilomentor
A New Merck, Reviewed
Liberal Arts Chemistry
Electron Pusher
All Things Metathesis
C&E News Blogs
Chemiotics II
Chemical Space
Noel O'Blog
In Vivo Blog
Terra Sigilatta
BBSRC/Douglas Kell
ChemBark
Realizations in Biostatistics
Chemjobber
Pharmalot
ChemSpider Blog
Pharmagossip
Med-Chemist
Organic Chem - Education & Industry
Pharma Strategy Blog
No Name No Slogan
Practical Fragments
SimBioSys
The Curious Wavefunction
Natural Product Man
Fragment Literature
Chemistry World Blog
Synthetic Nature
Chemistry Blog
Synthesizing Ideas
Business|Bytes|Genes|Molecules
Eye on FDA
Chemical Forums
Depth-First
Symyx Blog
Sceptical Chymist
Lamentations on Chemistry
Computational Organic Chemistry
Mining Drugs
Henry Rzepa


Science Blogs and News:
Bad Science
The Loom
Uncertain Principles
Fierce Biotech
Blogs for Industry
Omics! Omics!
Young Female Scientist
Notional Slurry
Nobel Intent
SciTech Daily
Science Blog
FuturePundit
Aetiology
Gene Expression (I)
Gene Expression (II)
Sciencebase
Pharyngula
Adventures in Ethics and Science
Transterrestrial Musings
Slashdot Science
Cosmic Variance
Biology News Net


Medical Blogs
DB's Medical Rants
Science-Based Medicine
GruntDoc
Respectful Insolence
Diabetes Mine


Economics and Business
Marginal Revolution
The Volokh Conspiracy
Knowledge Problem


Politics / Current Events
Virginia Postrel
Instapundit
Belmont Club
Mickey Kaus


Belles Lettres
Uncouth Reflections
Arts and Letters Daily
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

In the Pipeline

« The Root of All Results? | Main | Getting the Word Out, For Once »

March 22, 2004

Quis custodiet ipsos custodes?

Email This Entry

Posted by Derek

There's an interesting piece over at 2 Blowhards (a culture-blog I'm going to have to permalink soon) on business versus craft. Their example is from a Los Angeles Times article on animators. Many Californians in that trade have had their jobs fall victim to new technology (and new lower-wage sources of labor.) You'll think that you know where this is going, but just watch:

It's impossible not to feel for these people, since it is clear that collapse of Disney animation, at least, was hardly the fault of its lower-ranking employees. The Eddie Gorals of the animation world didn't screw up. No, clearly, the 'suits' are to blame here for bad business and artistic decisions (like the last four or five Disney animated movies, with the notable exception of "Lilo and Stitch.")

And yet, is it really fair to blame the 'suits'? Is it really the responsibility of the 'suits' to ensure that the Eddie Gorals of this world are employed at reasonably well-paid salaries doing what they love? Isn't part of the problem that the Eddie Gorals of this world want to beaver away at their craft, and don't want to be bothered to think about raising money and launching new projects that would ensure that they stay employed?

I know the tradeoff Eddie thought he was making-the 'suits' would get the big bucks and he would settle for a middle-class life-style coupled with a steady-stream of craftsmanly job satisfaction. But that didn't take into account the more-or-less inevitable outcome: that the suits (to whom Eddie had effectively outsourced the 'business' issues he preferred not to focus on) would screw up! It took them awhile, but they managed it. And he (not they) paid the price.

Blogger "Friedrich von Blowhard" makes a good point, and it's one that you don't hear made very often. It goes for the drug industry, too, as many of my readers there will have sensed immediately on reading the above. Employees at the smaller companies know this principle well, because so many of those companies collapse. Everyone working at a biotech has one eye on the exit, ready to bolt if things start to go bad.

But it works like that in the big companies, too, or it should. If you think that your high-flying pharma company is executing one of those slow, stately turns that will take it directly into the side of a mountain, you should start getting ready to jump. It can be hard, because there are often personal and family reasons to stay where you are. There's not always another place to go, either, and I appreciate that problem (having been there myself.)

It can also be tough to leave behind the vested bonuses, profit-sharing plans, and so on that your tenure entitles you to. You feel as if you can't afford to go anywher else. But those things are going to disappear if the company really does grind into the gravel, and that's when you can least stand to have it happen. I've seen some distressing examples among people who kept buying lots of their company stock in their retirement plans, for example, because it did so well. And because it did so well, it came to be a big fraction of their portfolio, well above the limits that they'll usually let you set for new purchases. And when said company began throwing piston rods and leaking oil, the stock tanked, taking all those retirement plans down with it. Then the bonuses stopped, and then the firings started.

No, Friedrich is right. You have to keep a clear eye on the people running your company. If you just read the company's official statements, and just listen to the stuff at the "State of the Firm" meetings, you'll think that everything is fine, even if it isn't.You need to think for yourself, and get all the external advice you can (from the investment community, the trade press, and so on.) Capitalism is work - that's one of the reason why it works.

Comments (0) | Category: Business and Markets | Life in the Drug Labs


COMMENTS

EMAIL THIS ENTRY TO A FRIEND

Email this entry to:

Your email address:

Message (optional):




RELATED ENTRIES
A Last Summer Day Off
The Early FDA
Drug Repurposing
The Smallest Drugs
Life Is Too Short For Some Journal Feeds
A New Look at Phenotypic Screening
Small Molecules - Really, Really Small
InterMune Bought